Ampa announced an $8.5M oversubscribed funding round led by Nexus NeuroTech Ventures and launched a nationwide rollout of its FDA-cleared Ampa One system. The raise follows Ampa emerging from stealth four months earlier and supports commercial expansion of its non-invasive brain stimulation device.
Comments
Want to join the conversation?
Loading comments...